Adiponectin levels do not appear to vary with menopausal status (96)
A Livea provider will review your current program and health profile to determine whether Lipo-B12 is the right next step
Severe neurological symptoms warrant urgent treatment
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
Some are clinically meaningful clues that point toward systemic disease, medication side effects, or conditions that deserve a closer look
